Sunday - April 19, 2026

Meera Gandhi hosts “UPLIFTNY 2025” to celebrate International Yoga Day on June 21, in Central Park, New York.

The Giving Back Foundation is a nonprofit organization promoting mental health, spiritual well-being, and community connection. Founded by Meera Gandhi, the foundation works globally to foster compassion, healing, and positive social change. New York – June 11, 2025 – The … Continue reading

High-grade Glioma Market Expected to Experience Major Growth by 2034, According to DelveInsight | Rigel Pharma, Orbus Therapeutics, BioMimetix, Bayer, MedImmune, DNAtrix, Chimerix, CNS Pharma

The Key High-grade Glioma Companies in the market include – Everfront Biotech Co., Ltd., BioMimetix JV, LLC, Chimerix, Laminar Pharmaceuticals, Nationwide Children’s Hospital, Rigel Pharmaceuticals, Orbus Therapeutics, BioMimetix, Bayer, MedImmune, DNAtrix, Chimerix, CNS Pharmaceuticals, VBI Vaccines, Kazia Therapeutics, Aivita Biomedical, … Continue reading

PCSK9 Inhibitors Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Statistics, Revenue, Pipeline, Therapies, and Companies by DelveInsight

PCSK9 Inhibitors Drugs Market PCSK9 Inhibitors Companies are Sirnaomics, Vaxxinity, Verve Therapeutics, Xinlitai Biotechnology, Novo Nordisk, AstraZeneca, Akeso Biopharma, Amgen, Jiangsu Hengrui Medicine Co., Innovent Biologics, LIB Therapeutics, AstraZeneca and Ionis Pharmaceuticals, CiVi Biopharma, and others. (Albany, USA) DelveInsight’s “PCSK9 … Continue reading

Alzheimer’s Disease Pipeline Appears Robust With 200+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Alzheimer’s Disease Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Alzheimer’s disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment … Continue reading

Polycystic Kidney Disease Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Polycystic Kidney Diseases Pipeline Insight, 2025” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Polycystic Kidney Diseases pipeline landscape. It covers the Polycystic Kidney Disease pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading

Chronic Obstructive Pulmonary Disease Market was valued at USD 16,075 million in 2023 and is expected to experience consistent growth by 2034, estimates DelveInsight

DelveInsight’s “Chronic Obstructive Pulmonary Disease Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the COPD, historical and forecasted epidemiology and the COPD market trends in the United States, EU4 (Germany, France, Italy, and Spain) … Continue reading

Systemic Sclerosis Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Systemic Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Systemic Sclerosis pipeline landscape. It covers the Systemic Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading